ADVERTISEMENT
Manila Bulletin devider Philippines devider National devider 'No problem, don't worry': Galvez guarantees that soon-to-expire AstraZeneca jabs won't go to waste

'No problem, don't worry': Galvez guarantees that soon-to-expire AstraZeneca jabs won't go to waste

Published May 13, 2021 10:59 am

Vaccine czar and National Task Force (NTF) Against COVID-19 chief implementer, Secretary Carlito Galvez Jr. has quelled public concern that around two million AstraZeneca vaccines might expire before they could get used in the government’s mass inoculation program against the coronavirus disease (COVID-19).

Vaccine czar, Secretary Carlito Galvez Jr. during the symbolic vaccination at Makati Medical Center on May 13, 2021. (Screengrab from, Facebook live)

"We believe yung sa AstraZeneca, we can manage that considering our daily inoculation right now is 83,000," Galvez told members of the media on the sidelines of a "symbolic" vaccination Thursday, May 13, at Makati Medical Center.

"When we computed the daily output that we have, kayang-kaya natin i-manage yung AstraZeneca (we can easily manage the AstraZeneca vaccines). By June 15 we are expecting na matatapos pong lahat yun (we will finish all of it)," he confidently added.

There have been reports that the British-Swedish jabs that the country has in its inventory would expire soon, triggering fears of massive wastage of the precious commodity.

Galvez confirmed that two vaccines--AstraZeneca and the Russian made Sputnik V--have relatively short shelf life.

He said the AstraZeneca vaccines on hand have two expiration dates. One batch of almost 1.5 million jabs will expire on June 30, while another batch of 525,600 doses will expire sometime in July.

"Yung una is June 30 (Those expiring on June 30), almost 1.5 million which will be administered as first dose. The second dose, yung 525,600, its expiration is July (Those expiring in July will be used for the second dose)," he explained "So wala tayong problema, don't worry. Kaya ng mga logistics namin yan (So we don't have any problem, don't worry, Our logistics can handle it). We are rehearsing this for a long, long time, yung ating rollout (our rollout)," added the vaccine czar.

"Sinabihan natin yung ating mga vaccination sites na unahin muna yung AstraZeneca vaccines (We've told our vaccination sites to prioritize the use of AstraZeneca vaccines)," Galvez said.

As for the country’s daily capacity for inoculations against the dreaded COVID-19, Galvez said: "It's going to increase over the considering we are increasing our capacity and we are activating more vaccination sites." The United States (US)-manufactured Pfizer vaccines were used during the symbolic vaccination Thursday.

Related Tags

vaccines NTF AstraZeneca june galvez July expire expiration
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.